Polyvalent pneumococcal vaccine

Known as: PPSV, Pneumococcal Polysaccharide Vaccine [Chemical/Ingredient], Pneumococcal Polyvalent Vaccine 
An polyvalent vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. Pneumococcal polyvalent vaccine contains highly purified… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
INTRODUCTION The WHO recommends annual influenza vaccination to prevent influenza illness in high-risk groups. Little is known… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Review
2016
Review
2016
This review describes development of currently available pneumococcal vaccines, provides summary tables of current pneumococcal… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Background Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and sepsis in children worldwide… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Changes in invasive pneumococcal disease (IPD) incidence were evaluated after 7 years of 7-valent pneumococcal… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in the United States (US) in 2000 and has significantly… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE To monitor clinical and microbiologic features including antimicrobial susceptibility and serogroup distribution of… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND In early 2000, a protein-polysaccharide conjugate vaccine targeting seven pneumococcal serotypes was licensed in the… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Ear infections are a common cause of illness during the first two years of life. New conjugate vaccines may be able to… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
OBJECTIVE To determine pneumococcal polysaccharide vaccine efficacy in selected populations at risk for serious pneumococcal… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
BACKGROUND Although the protective efficacy of pneumococcal polysaccharide vaccine has been demonstrated in randomized trials in… (More)
Is this relevant?